Executive Team

Co-Founder, Chief Executive Officer

Eric F. Bernstein, M.D., M.S.E.

  • Founder/Director of the Main Line Center for Laser Surgery, which recently joined PE-backed, Advanced Medesthetic Partners.
  • Served as president of the ASLMS, serves as a director for the ASDS, and serves on numerous laser company scientific advisory boards, and was a Director for Candela Corporation.
  • Founded and recently sold Alethia, LLC, a skincare company with the associated IP to a privately held aesthetic company.
  • Currently serves as volunteer faculty at the University of Pennsylvania and Temple University in the Department of Dermatology as a Clinical Professor. He has authored over 100 peer-reviewed articles and over 15 U.S. and international patents in addition to giving more than 400 presentations at scientific meetings.
  • Duke University, B.S. and Yale University School of Medicine, M.D.

Co-Founder, Chief Technology Officer

Tian Wang, Ph.D.

  • CEO, Founder and Owner of L’Onvie Inc. a powerhouse of research, product development and manufacturing

  • Former Executive Director Applied Technology at Estee Lauder, Manager Advanced Makeup Technology at Revlon, and Scientist in Skin and Haircare Division at P&G

Chief Operating Officer

Andrew Levenkron

  • Andy Levenkron (COO) has over 30 years of experience in supply chain management and operations with personal care brands.

  • He has coordinated the launch of over 100 beauty products and brings a deep knowledge of forecasting, cash management, cost of goods planning, manufacturing quality assurance and quality control.

Medical Advisory Board

Investor, Co-Chair

Kavita Mariwalla, M.D., FAAD

• Double board certified in dermatology and
dermatologic surgery

• Author of 4 books including Cosmeceutical Compendium

• Yale University School of Medicine

• President-elect of American Society of Dermatologic Surgery

Investor, Co-Chair

Amy Lewis, M.D., FAAD

• World-renown expert on aesthetic
dermatology

• Founded the Yale Cosmetic Dermatology Division

• Yale University School of Medicine

Chair

Yann Echelard, Ph.D.

• Operating Partner of Flagship Pioneering

• Roche Institute and Harvard University Developmental Biology isolation and characterization of Hedgehog genes

• First goat somatic cell transfer (cloning) and developed goats as bioreactors

• President and CEO of EVO Biologics

• Founding President of Ring Therapeutircs Cellularity and co-founder of Laronde, ProFound Therapeutics, Ampersand biomedicine and other companies